000008364 001__ 8364
000008364 005__ 20240328153319.0
000008364 0247_ $$2DOI$$a10.6083/s1784m41b
000008364 037__ $$aIR
000008364 041__ $$aeng
000008364 245__ $$aClinical dosimetry tool implementation of I-131 MIBG therapy for pheochromocytoma and paraganglioma
000008364 260__ $$bOregon Health and Science University
000008364 269__ $$a2020
000008364 336__ $$aAbstract
000008364 520__ $$aThe purpose of this project is to calculate a therapeutic activity that assures the limit doses are not exceeded for critical organs in patients undergoing the I-131 MIBG / AZEDRA (Progenics Pharmaceuticals, Tarrytown, NY) therapy for pheochromocytoma and paraganglioma.
000008364 540__ $$fCC BY
000008364 542__ $$fIn copyright - joint owners
000008364 650__ $$aPheochromocytoma$$023980
000008364 650__ $$aParaganglioma$$023555
000008364 650__ $$aRadiation Monitoring$$025073
000008364 6531_ $$amibg
000008364 6531_ $$aiodine-131
000008364 6531_ $$atheragnostic
000008364 6531_ $$adosimetry
000008364 6531_ $$aazedra
000008364 691__ $$aSchool of Medicine$$041369
000008364 692__ $$aDepartment of Diagnostic Radiology$$041407
000008364 7001_ $$aFranco, Roberto P.$$uOregon Health and Science University$$041354
000008364 7001_ $$aPugachev, Andrei$$uOregon Health and Science University$$041354
000008364 711__ $$aResearch Week$$uOregon Health and Science University$$d2020
000008364 8564_ $$9eceabcdf-3fc4-4fbc-b521-aaf10e47bbf8$$s46402$$uhttps://digitalcollections.ohsu.edu/record/8364/files/ResearchWeek.2020.Franco.Roberto.pdf
000008364 905__ $$a/rest/prod/s1/78/4m/41/s1784m41b
000008364 980__ $$aResearch Week